Macrophage foam cell formation is augmented in serum from patients with diabetic angiopathy

Diabetes Research and Clinical Practice

Volumn 87, Issue 1, 2010, Pages 57-63

  Cui, Xinglong ^a   Kushiyama, Akifumi ^b   Yoneda, Masayasu ^a   Nakatsu, Yusuke ^a   Guo, Ying ^a   Zhang, Jun ^a   Ono, Haruya ^a   Kanna, Machi ^a   Sakoda, Hideyuki ^c   Ono, Hiraku ^d   Kikuchi, Takako ^b   Fujishiro, Midori ^c   Shiomi, Masashi ^e   Kamata, Hideaki ^a   Kurihara, Hiroki ^c   Kikuchi, Masatoshi ^b   Kawazu, Shoji ^b   Nishimura, Fusanori ^f   Asano, Tomoichiro ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b INSTITUTE FOR ADULT DISEASES   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f Graduate School of Biomedical Sciences   (Japan)

Author keywords

Diabetic angiopathy; Ex vivo assay; Foam cell; Macrophage

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; ANTITHROMBOCYTIC AGENT; BIGUANIDE DERIVATIVE; CHOLESTEROL ESTER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; SULFONYLUREA DERIVATIVE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; FEMALE; FOAM CELL; HUMAN; LIPID STORAGE; MALE; MASS FRAGMENTOGRAPHY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEINURIA; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BLOOD PRESSURE; BODY MASS INDEX; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; DIABETIC ANGIOPATHIES; FEMALE; FOAM CELLS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LEUKOCYTE COUNT; LIPIDS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIVER FUNCTION TESTS; MACROPHAGES; MALE; MICE; RABBITS; REGRESSION ANALYSIS;

EID: 73749088655     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.10.011     Document Type: Article

References (30)

1. Tesch. Role of macrophages in complications of type 2 diabetes. Clin. Exp. Pharmacol. Physiol. 34 (2007) 1016-1019
2. Nguyen, Ping, Mu, Hill, Atkins, and Chadban. Macrophage accumulation in human progressive diabetic nephropathy. Nephrology (Carlton) 11 (2006) 226-231
3. Boyle. Diabetes mellitus and macrovascular disease: mechanisms and mediators. Am. J. Med. 120 (2007) S12-17
4. Simionescu. Implications of early structural-functional changes in the endothelium for vascular disease. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 266-274
5. Gacka, Dobosz, Szymaniec, Bednarska-Chabowska, Adamiec, and Sadakierska-Chudy. Proinflammatory and atherogenic activity of monocytes in Type 2 diabetes. J. Diabetes Complications (2008)
6. Hodgkinson, Laxton, Patel, and Ye. Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 2275-2281
7. Ishigaki, Katagiri, Gao, Yamada, Imai, Uno, et al. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis. Circulation 118 (2008) 75-83
8. Mori, Itabe, Higashi, Fujimoto, Shiomi, Yoshizumi, et al. Foam cell formation containing lipid droplets enriched with free cholesterol by hyperlipidemic serum. J. Lipid Res. 42 (2001) 1771-1781
9. Shiomi, Ito, Yamada, Kawashima, and Fan. Development of an animal model for spontaneous myocardial infarction (WHHLMI rabbit). Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1239-1244
10. Tanzawa, Shimada, Kuroda, Tsujita, Arai, and Watanabe. WHHL-rabbit: a low density lipoprotein receptor-deficient animal model for familial hypercholesterolemia. FEBS Lett. 118 (1980) 81-84
11. Buja, Kita, Goldstein, Watanabe, and Brown. Cellular pathology of progressive atherosclerosis in the WHHL rabbit. An animal model of familial hypercholesterolemia. Arteriosclerosis 3 (1983) 87-101
12. Shiomi, Ito, Shiraishi, and Watanabe. Inheritability of atherosclerosis and the role of lipoproteins as risk factors in the development of atherosclerosis in WHHL rabbits: risk factors related to coronary atherosclerosis are different from those related to aortic atherosclerosis. Atherosclerosis 96 (1992) 43-52
13. Ishii, Kita, Yokode, Kume, Nagano, Otani, et al. Characterization of very low density lipoprotein from Watanabe heritable hyperlipidemic rabbits. J. Lipid Res. 30 (1989) 1-7
14. Ito, Yamada, and Shiomi. Progression of coronary atherosclerosis relates to the onset of myocardial infarction in an animal model of spontaneous myocardial infarction (WHHLMI rabbits). Exp. Anim. 53 (2004) 339-346
15. Greenspan, and Fowler. Spectrofluorometric studies of the lipid probe, nile red. J. Lipid Res. 26 (1985) 781-789
16. Kushiyama, Shojima, Ogihara, Inukai, Sakoda, Fujishiro, et al. Resistin-like molecule beta activates MAPKs, suppresses insulin signaling in hepatocytes, and induces diabetes, hyperlipidemia, and fatty liver in transgenic mice on a high fat diet. J. Biol. Chem. 280 (2005) 42016-42025
17. Fukuda. Classification and treatment of diabetic retinopathy. Diabetes Res. Clin. Pract. 24 Suppl. (1994) S171-176
18. Veglio, Paglieri, Rabbia, Bisbocci, Bergui, and Cerrato. Hypertension and cerebrovascular damage. Atherosclerosis (2008)
19. Silva, Pinto, Biswas, de Faria, and de Faria. Hypertension increases retinal inflammation in experimental diabetes: a possible mechanism for aggravation of diabetic retinopathy by hypertension. Curr. Eye Res. 32 (2007) 533-541
20. Avogaro, de Kreutzenberg, and Fadini. Endothelial dysfunction: causes and consequences in patients with diabetes mellitus. Diabetes Res. Clin. Pract. 82 Suppl. 2 (2008) S94-S101
21. Vaidyula, Boden, and Rao. Platelet and monocyte activation by hyperglycemia and hyperinsulinemia in healthy subjects. Platelets 17 (2006) 577-585
22. Sugimoto, Baba, Suda, Yasujima, and Yagihashi. Peripheral neuropathy and microangiopathy in rats with insulinoma: association with chronic hyperinsulinemia. Diabetes Metab. Res. Rev. 19 (2003) 392-400
23. Yang, Shi, Hao, Li, and Le. Increasing oxidative stress with progressive hyperlipidemia in human: relation between malondialdehyde and atherogenic index. J. Clin. Biochem. Nutr. 43 (2008) 154-158
24. Ogihara, Asano, Katagiri, Sakoda, Anai, Shojima, et al. Oxidative stress induces insulin resistance by activating the nuclear factor-kappa B pathway and disrupting normal subcellular distribution of phosphatidylinositol 3-kinase. Diabetologia 47 (2004) 794-805
25. Osto, Matter, Kouroedov, Malinski, Bachschmid, Camici, et al. c-Jun N-terminal kinase 2 deficiency protects against hypercholesterolemia-induced endothelial dysfunction and oxidative stress. Circulation 118 (2008) 2073-2080
26. Kakehashi, Inoda, Mameuda, Kuroki, Jono, Nagai, et al. Relationship among VEGF, VEGF receptor, AGEs, and macrophages in proliferative diabetic retinopathy. Diabetes Res. Clin. Pract. 79 (2008) 438-445
27. Yoshino, Hirano, Nagata, Maeda, Naka, Murata, et al. Hypertriglyceridemia in nephrotic rats is due to a clearance defect of plasma triglyceride: overproduction of triglyceride-rich lipoprotein is not an obligatory factor. J. Lipid Res. 34 (1993) 875-884
28. Wong, Molyneaux, Constantino, Twigg, and Yue. Timing is everything: age of onset influences long-term retinopathy risk in type 2 diabetes, independent of traditional risk factors. Diabetes Care 31 (2008) 1985-1990
29. Chiasson, Josse, Gomis, Hanefeld, Karasik, and Laakso. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359 (2002) 2072-2077
30. PROactive study. Lancet 367 (2006) 982